VR

Victoria M. Richon

SR Sloan Kettering Institute For Cancer Research: 13 patents #26 of 644Top 5%
EP Epizyme: 9 patents #21 of 65Top 35%
Merck: 9 patents #1,283 of 9,382Top 15%
CU Columbia University: 5 patents #264 of 2,492Top 15%
📍 Wellesley, MA: #51 of 837 inventorsTop 7%
🗺 Massachusetts: #3,464 of 88,656 inventorsTop 4%
Overall (All Time): #137,107 of 4,157,543Top 4%
28
Patents All Time

Issued Patents All Time

Showing 1–25 of 28 patents

Patent #TitleCo-InventorsDate
11633420 Method of treating leukemia Edward J. Olhava, Richard Chesworth, Kevin Wayne Kuntz, Roy M. Pollock, Scott R. Daigle 2023-04-25
10881680 Method of treating leukemia Edward J. Olhava, Richard Chesworth, Kevin Wayne Kuntz, Roy M. Pollock, Scott R. Daigle 2021-01-05
9949999 Inhibitors of human EZH2, and methods of use thereof Robert A. Copeland, Margaret D. Scott, Christopher J. Sneeringer, Kevin Wayne Kuntz, Sarah K. Knutson +1 more 2018-04-24
9597348 Method of treating leukemia Edward J. Olhava, Richard Chesworth, Kevin Wayne Kuntz, Roy M. Pollock, Scott R. Daigle 2017-03-21
9333217 Inhibitors of human EZH2, and methods of use thereof Robert A. Copeland, Margaret D. Scott, Christopher J. Sneeringer, Kevin Wayne Kuntz, Sarah K. Knutson +1 more 2016-05-10
9096634 Substituted purine and 7-deazapurine compounds Edward J. Olhava, Richard Chesworth, Kevin Wayne Kuntz, Roy M. Pollock, Scott R. Daigle 2015-08-04
8895245 Inhibitors of human EZH2 and methods of use thereof Robert A. Copeland, Margaret D. Scott, Christopher J. Sneeringer, Kevin Wayne Kuntz, Sarah K. Knutson +1 more 2014-11-25
8691507 Inhibitors of human EZH2 and methods of use thereof Robert A. Copeland, Margaret D. Scott, Christopher J. Sneeringer, Kevin Wayne Kuntz, Sarah K. Knutson +1 more 2014-04-08
8580762 Substituted purine and 7-deazapurine compounds Edward J. Olhava, Richard Chesworth, Kevin Wayne Kuntz, Roy M. Pollock, Scott R. Daigle 2013-11-12
8101663 Polymorphs of suberoylanilide hydroxamic acid Thomas A. Miller 2012-01-24
8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma Judy H. Chiao, William Kevin Kelly, Thomas A. Miller 2011-11-29
7879865 Treatment of cancer of the brain using histone deacetylase inhibitors Paul A. Marks, Richard A. Rifkind 2011-02-01
7851509 Polymorphs of suberoylanilide hydroxamic acid Thomas A. Miller 2010-12-14
7816499 Antibodies that selectively bind HDAC9 Xianbo Zhou, Richard A. Rifkind, Paul A. Marks 2010-10-19
7799803 Hydroxamic acid compounds and methods of use thereof Ronald Breslow, Thomas A. Miller, Sandro Belvedere, Paul A. Marks, Richard A. Rifkind 2010-09-21
7732490 Methods of treating cancer Judy H. Chiao, William Kevin Kelly, Thomas A. Miller 2010-06-08
7652069 Polymorphs of suberoylanilide hydroxamic acid Thomas A. Miller 2010-01-26
7456219 Polymorphs of suberoylanilide hydroxamic acid Thomas A. Miller, Judy H. Chiao 2008-11-25
7399787 Methods of treating cancer with HDAC inhibitors Judy H. Chiao, Nicholas Bacopoulos, Thomas A. Miller, Carolyn Paradise 2008-07-15
7375137 Methods of treating cancer with HDAC inhibitors Nicholas Bacopoulos, Judy H. Chiao, Thomas A. Miller, Carolyn Paradise 2008-05-20
7345174 Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof Ronald Breslow, Sandro Belvedere, Leland Gershell, Thomas A. Miller, Paul A. Marks +1 more 2008-03-18
7244604 HDAC9 polypeptides and polynucleotides and uses thereof Xianbo Zhou, Richard A. Rifkind, Paul A. Marks 2007-07-17
7199134 Hydroxamic acid compounds and methods of use thereof Ronald Breslow, Thomas A. Miller, Sandro Belvedere, Paul A. Marks, Richard A. Rifkind 2007-04-03
7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid Nicholas Bacopoulos, Judy H. Chiao, Thomas A. Miller, Carolyn Paradise 2006-12-12
7126001 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof Ronald Breslow, Sandro Belvedere, Leland Gershell, Thomas A. Miller, Paul A. Marks +1 more 2006-10-24